Early stopping rules--clinical perspectives and ethical considerations

Area of Science:

• Clinical research methodology
• Medical ethics

Background:

• Clinical trial equipoise is essential for ethical research.
• Equipoise can fluctuate during patient recruitment.
• Premature trial termination may be necessary due to toxicity or lack of efficacy.

Purpose of the Study:

• To examine the dynamic nature of equipoise during clinical trials.
• To argue for a flexible approach to trial continuation decisions.
• To highlight the role of Data Monitoring Committees in managing equipoise.

Main Methods:

• Analysis of equipoise dynamics in four specific clinical trials.
• Review of factors influencing equipoise levels during recruitment.
• Case study approach to illustrate decision-making processes.

Main Results:

• Equipoise levels are not static and can be influenced by trial data and external evidence.
• Definitive rules for trial continuation are insufficient.
• Data Monitoring Committees are vital for adaptive trial management.

Conclusions:

• Decisions on continuing clinical trials require ongoing assessment of equipoise.
• Data Monitoring Committees provide the necessary oversight for dynamic equipoise management.
• Ethical trial conduct necessitates a responsive approach to evolving evidence.